Benitec BiopharmaBNTC

13F holders, Q2 2024 (June 30)
1holders
$6.99avg. 13F price*

At the end of Q2 2024, 1 institutions reported holding Benitec Biopharma Inc. (BNTC) in their 13F filings. The largest holder was AWM Investment Company, Inc. ($4.4M).

Company
Benitec Biopharma Inc.
CUSIP
08205P100
Latest filing quarter
Q2 2024

Total Exit/New Position Q2 2024

InstitutionsTotal Value
New Positions1$4.4M
Exits0$0

Ownership 1 holders

AWM Investment Company, Inc. 0.59% New 625,000 $4.4M

"% of holder's portfolio" is BNTC's weight in each manager's 13F, not the share of Benitec Biopharma Inc. the manager owns.